(1,5-Dimethyl-1H-indazol-4-yl)boronic acid

Catalog No. :
ACTNCW325
CAS No. :
1262512-81-1
Molecular Formula :
C9H11BN2O2
Molecular Weight :
190.01

IUPAC Name:(1,5-dimethyl-1H-indazol-4-yl)boronic acid

(1,5-Dimethyl-1H-indazol-4-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$75.00Login to see priceIn stockInquiry
250mg98%$112.00Login to see priceIn stockInquiry
1g98%$277.00Login to see priceIn stockInquiry
5g98%$1302.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1,5-Dimethyl-1H-indazol-4-yl)boronic acid
IUPAC Name(1,5-dimethyl-1H-indazol-4-yl)boronic acid
MDL No.MFCD12028651
Molecular FormulaC9H11BN2O2
Molecular Weight190.01
SMILESCC1=C(B(O)O)C2=C(N(C)N=C2)C=C1
InChI KeyHXZJNUVDIOSKNT-UHFFFAOYSA-N
Synonym(1,5-dimethyl-1H-indazol-4-yl)boronic acid;(1,5-dimethylindazol-4-yl)boronic acid;(1,4-dimethylindazol-5-yl)boronic acid;Boronic acid, B-(1,5-dimethyl-1H-indazol-4-yl)-;(1,5-Dimethyl-1H-indazol-4-yl)boronic acid - [D88430]
CAS No.1262512-81-1
PubChem CID44119487

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTNCW325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKDXP172 route compound structure diagram
    ACKDXP1721245816-10-7 In Stock
  4. Then
  5. ACTNCW325 route product structure diagram
    ACTNCW3251262512-81-1 In Stock
Inquiry

2. ACTNCW325 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTNCW325 route product structure diagram
    ACTNCW3251262512-81-1 In Stock
Inquiry

Comments (0)